BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bayaa R, Ndiaye MDB, Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S, Nasrin R, Ranaivomanana P, Raherinandrasana AH, Rakotonirina J, Rasolofo V, Delogu G, De Maio F, Goletti D, Endtz H, Ader F, Hamze M, Ismail MB, Pouzol S, Rakotosamimanana N, Hoffmann J; HINTT working group within the GABRIEL network. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. Sci Rep 2021;11:13646. [PMID: 34211042 DOI: 10.1038/s41598-021-93059-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kaforou M, Broderick C, Vito O, Levin M, Scriba TJ, Seddon JA. Transcriptomics for child and adolescent tuberculosis. Immunol Rev 2022. [PMID: 35818983 DOI: 10.1111/imr.13116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front Microbiol 2021;12:745592. [PMID: 34745048 DOI: 10.3389/fmicb.2021.745592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wykowski JH, Phillips C, Ngo T, Drain PK. A systematic review of potential screening biomarkers for active TB disease. J Clin Tuberc Other Mycobact Dis 2021;25:100284. [PMID: 34805557 DOI: 10.1016/j.jctube.2021.100284] [Reference Citation Analysis]